Macrophage development and specification in mice.
小鼠巨噬细胞的发育和规范。
基本信息
- 批准号:10153684
- 负责人:
- 金额:$ 60.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-02-08 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAlveolar MacrophagesAnatomyAntigen-Presenting CellsBlood VesselsBone MarrowBone Marrow TransplantationBrainCell Differentiation processCellsClinicalComplexCuesDegenerative DisorderDevelopmentDevelopmental ProcessDiseaseEmbryoEmbryonic DevelopmentEnhancersEpithelialErythroEventFamilyFetal DevelopmentFilopodiaGeneticGenetic PolymorphismGenetic TranscriptionGenomicsGlycoproteinsGoalsGrowthGrowth FactorHealthHematopoietic stem cellsHomeostasisImmuneIn SituIn VitroInflammationInflammatoryInflammatory ResponseInvestigationKidneyKupffer CellsLabelLaboratoriesLamina PropriaLangerhans cellLipidsLiteratureLiverLungMaintenanceMethodsMicrogliaModelingMolecularMononuclearMorphogenesisMusMyelogenousMyeloid CellsNatural ImmunityNeurophysiology - biologic functionOrganOrganogenesisPathogenesisPatternPhagocytesPhenotypePlayPopulationProcessRegulationResearchRoleSentinelSpecific qualifier valueSupporting CellSystemSystems BiologyTestingTissue DifferentiationTissuesWorkYolk Sacantimicrobialbrain cellcell motilitycell typeepidermis cellexpectationglobal healthin vivoinsightirradiationlymphatic vesselmacrophagemembermonocyteneurogenesisnovelpathogenpostnatalprogenitorprogramsrecruitrepairedspatiotemporaltissue repairtooltranscription factortranscriptome sequencingtransplant modeltumoruptake
项目摘要
Project Summary
Macrophages are a diverse family of professional phagocytes and `accessory cells' present within most
tissues, and equipped with long and motile filopodia that continuously explore surrounding matrix and cells.
Macrophages recognize and scavenge pathogens as well as unfit cells and cell debris, glycoproteins and
lipids, and produce a large range of bioactive molecules and growth factors.
A literature that covers 150 years of research has demonstrated their important and complex roles (i) as innate
immune sentinels for the uptake of pathogens, but also as (ii) regulators of epithelia and blood and lymphatic
vessels morphogenesis during fetal development, postnatal homeostasis and tissue remodeling, and
inflammatory and degenerative processes. An overarching hypothesis that drives the present proposal and the
work of our laboratory is that the understanding the genetic and molecular events that control development,
growth, and maintenance of macrophages within tissues is essential to elucidate their roles in disease and the
consequence(s) of genetic polymorphisms.
Early studies suggested that tissue macrophages originate and renew from hematopoietic stem cells (HSC) via
circulating progenitors such as blood monocytes. However, as recently shown by us and others, monocytes
and macrophages play different roles in disease pathogenesis, and in fact, they represent distinct cell types, as
most tissue-resident macrophages develop from embryonic progenitors distinct from HSCs and are maintained
in postnatal tissues independently of bone marrow progenitors and monocytes. Furthermore, macrophages
that reside in distinct tissues present with different molecular identities and functions. The tissue-specific
identities of macrophages are in part maintained by their local microenvironment, but are also likely to result
from developmental processes.
The present project builds on these exciting and `paradigm-changing' developments. 1) We will characterize
the genetic and molecular determinants that control macrophage development from embryonic progenitors in
the mouse, using sate-of-the-art fate mapping methods, and explore the mechanisms that underlie the
colonization of embryos by the macrophages precursors. 2) We will also take advantage of single-cell genomic
and systems biology approaches to characterize the mechanisms and spatio-temporal sequence of events
responsible for tissue macrophage specification in vivo. We will further test the role of novel key transcriptional
regulators that control macrophage differentiation, maintenance, and functions in postnatal tissues, with a
focus on Kupffer cells. Along this process we will generate novel genetic tools needed to distinguish and
selectively target tissue-resident macrophages, independently of HSC and their progeny. Altogether, this work
represents a ground-breaking advance toward our aim to characterize the function of tissue-resident
macrophage in health and disease.
项目摘要
巨噬细胞是存在于大多数细胞中的专职吞噬细胞和“辅助细胞”的多样化家族。
组织,并配备长而能动的丝状伪足,不断探索周围的基质和细胞。
巨噬细胞识别并清除病原体以及不适合的细胞和细胞碎片、糖蛋白和
脂质,并产生大范围的生物活性分子和生长因子。
一项涵盖150年研究的文献表明,它们具有重要而复杂的作用:(i)与生俱来的
用于病原体摄取的免疫哨兵,但也作为(ii)上皮细胞和血液及淋巴的调节剂
胎儿发育期间的血管形态发生、出生后的体内平衡和组织重塑,以及
炎症和退化过程。驱动本提案的总体假设和
我们实验室的工作是了解控制发育的遗传和分子事件,
巨噬细胞在组织内的生长和维持对于阐明它们在疾病中的作用是必不可少的,
遗传多态性的后果。
早期的研究表明,组织巨噬细胞起源于造血干细胞(HSC),并通过
循环祖细胞,例如血液单核细胞。然而,正如我们和其他人最近所示,单核细胞
和巨噬细胞在疾病发病机制中发挥不同的作用,事实上,它们代表不同的细胞类型,
大多数组织驻留巨噬细胞从不同于HSC的胚胎祖细胞发育而来,
在出生后的组织中独立于骨髓祖细胞和单核细胞。此外,巨噬细胞
它们存在于不同的组织中,具有不同的分子身份和功能。组织特异
巨噬细胞的特性部分由其局部微环境维持,但也可能导致
来自发展过程。
本项目以这些令人兴奋的“改变范式”的发展为基础。1)我们将描述
控制巨噬细胞从胚胎祖细胞发育的遗传和分子决定因素,
小鼠,使用最先进的命运映射方法,并探索其背后的机制,
巨噬细胞前体对胚胎的定植。2)我们还将利用单细胞基因组
和系统生物学的方法来表征的机制和时空序列的事件
负责体内组织巨噬细胞的特化。我们将进一步测试新的关键转录因子的作用,
在出生后组织中控制巨噬细胞分化、维持和功能的调节剂,
专注于枯否细胞沿着这一过程,我们将产生新的遗传工具,
选择性靶向组织驻留巨噬细胞,独立于HSC及其后代。总之,这项工作
代表了我们的目标是表征组织驻留功能的突破性进展,
巨噬细胞在健康和疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frederic Geissmann其他文献
Frederic Geissmann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frederic Geissmann', 18)}}的其他基金
Role of Microglia somatic variants in Neurodegenerative diseases
小胶质细胞体细胞变异在神经退行性疾病中的作用
- 批准号:
10011909 - 财政年份:2019
- 资助金额:
$ 60.41万 - 项目类别:
Role of Microglia Somatic Variants in Neurodegenerative Diseases
小胶质细胞体细胞变异在神经退行性疾病中的作用
- 批准号:
10631174 - 财政年份:2019
- 资助金额:
$ 60.41万 - 项目类别:
Role of Microglia somatic variants in Neurodegenerative diseases
小胶质细胞体细胞变异在神经退行性疾病中的作用
- 批准号:
10183354 - 财政年份:2019
- 资助金额:
$ 60.41万 - 项目类别:
Role of Microglia somatic variants in Neurodegenerative diseases
小胶质细胞体细胞变异在神经退行性疾病中的作用
- 批准号:
9789572 - 财政年份:2019
- 资助金额:
$ 60.41万 - 项目类别:
Role of Microglia somatic variants in Neurodegenerative diseases
小胶质细胞体细胞变异在神经退行性疾病中的作用
- 批准号:
10411914 - 财政年份:2019
- 资助金额:
$ 60.41万 - 项目类别:
Lineages and pathophysiology of clonal histiocytic disorders
克隆组织细胞疾病的谱系和病理生理学
- 批准号:
10001080 - 财政年份:2017
- 资助金额:
$ 60.41万 - 项目类别:
Lineages and pathophysiology of clonal histiocytic disorders
克隆组织细胞疾病的谱系和病理生理学
- 批准号:
9754257 - 财政年份:2017
- 资助金额:
$ 60.41万 - 项目类别:
Development of the resident macrophage lineage in mouse and human
小鼠和人类常驻巨噬细胞谱系的发展
- 批准号:
10660034 - 财政年份:2017
- 资助金额:
$ 60.41万 - 项目类别:
Lineages and pathophysiology of clonal histiocytic disorders
克隆组织细胞疾病的谱系和病理生理学
- 批准号:
9367862 - 财政年份:2017
- 资助金额:
$ 60.41万 - 项目类别:
Macrophage development and specification in mice.
小鼠巨噬细胞的发育和规范。
- 批准号:
9289988 - 财政年份:2017
- 资助金额:
$ 60.41万 - 项目类别:
相似海外基金
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
- 批准号:
23K08315 - 财政年份:2023
- 资助金额:
$ 60.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MICA: Key mechanisms underlying inhaled GM-CSF's enhancement of phagocytosis and bacterial clearance by human alveolar macrophages.
MICA:吸入 GM-CSF 增强人肺泡巨噬细胞吞噬作用和细菌清除的关键机制。
- 批准号:
MR/X005046/1 - 财政年份:2023
- 资助金额:
$ 60.41万 - 项目类别:
Research Grant
Analysis of pathogenic alveolar macrophages which release IL-1alpha in response to fine particles.
分析响应细颗粒物释放 IL-1α 的致病性肺泡巨噬细胞。
- 批准号:
23H03154 - 财政年份:2023
- 资助金额:
$ 60.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Glutamine Metabolism in Alveolar Macrophages following Influenza A Infection
甲型流感感染后肺泡巨噬细胞的谷氨酰胺代谢
- 批准号:
10607319 - 财政年份:2023
- 资助金额:
$ 60.41万 - 项目类别:
The function and regulation of tissue resident alveolar macrophages turnover by host and environmental factors during homeostasis and in infections
稳态和感染期间宿主和环境因素对组织驻留肺泡巨噬细胞周转的功能和调节
- 批准号:
471247 - 财政年份:2022
- 资助金额:
$ 60.41万 - 项目类别:
Fellowship Programs
Using a Lung on Chip Device to Study Alveolar Macrophages as Intracellular Reservoirs for Staphylococcus aureus
使用肺芯片装置研究肺泡巨噬细胞作为金黄色葡萄球菌的细胞内储库
- 批准号:
485971 - 财政年份:2022
- 资助金额:
$ 60.41万 - 项目类别:
Studentship Programs
Analysis of innate immune response of alveolar macrophages and epithelial-mesenchymal transition of alveolar epithelial cells
肺泡巨噬细胞的先天免疫反应和肺泡上皮细胞的上皮间质转化分析
- 批准号:
22K06698 - 财政年份:2022
- 资助金额:
$ 60.41万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Cholesterol crystal-mediated inflammation in alveolar macrophages: an emerging role inidiopathic lung fibrosis?
胆固醇晶体介导的肺泡巨噬细胞炎症:在特发性肺纤维化中的新兴作用?
- 批准号:
462596862 - 财政年份:2021
- 资助金额:
$ 60.41万 - 项目类别:
WBP Position
Elucidation of idiopathic pneumonia syndrome: Angiotensin 2 activates alveolar macrophages
特发性肺炎综合征的阐明:血管紧张素 2 激活肺泡巨噬细胞
- 批准号:
21K16251 - 财政年份:2021
- 资助金额:
$ 60.41万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Establishment of novel macrophage cell lines to study the pathogenesis of respiratory bacterial pathogens in lung alveolar macrophages
建立新型巨噬细胞系以研究肺泡巨噬细胞中呼吸道细菌病原体的发病机制
- 批准号:
NC/V001019/1 - 财政年份:2021
- 资助金额:
$ 60.41万 - 项目类别:
Research Grant














{{item.name}}会员




